Clinical Trials Logo

Clinical Trial Summary

Hospital rehospitalizations within 30 days are frequent and represent a burden for the patients, but also for the entire health care system. This study evaluates the impact of an intervention targeted to high-risk medical patients in order to reduce their risk of rehospitalization. Half of the patients will receive a set of interventions before and after their hospital discharge, while the other half will receive usual care.

Clinical Trial Description

Background: Hospital readmissions within 30 days are frequent, with rates varying usually between 12 and 20%. Is it therefore recognized as important to improve the quality of the transition of care period in order to avoid as much as possible hospital readmissions. There are however still several gaps in current knowledges. First, most trials to reduce hospital readmission have been performed on specific patient populations such as patients with diabetes or heart failure, and therefore the findings may not be well generalizable to other high-risk population. Second, while some specific interventions have been showed to reduce readmission, these were complex and resources demanding, and no trial targeted these interventions to the patients who are most likely to benefit for better effectiveness, using a widely validated prediction tool, such as the "HOSPITAL" score. Finally, most studies tested unimodal interventions instead of more promising multimodal interventions.

Specific aim: the goal of this proposal is to evaluate the effect of a multimodal transitional care intervention prioritized to higher-risk medical patients on the composite of 30-day unplanned readmissions and death.

Methods: the investigators will conduct a multicenter randomized controlled trial in medical inpatients discharged home or nursing home, who are identified as having a higher risk for 30-day readmission. Risk of readmission will be predicted using the simplified HOSPITAL score, which includes 6 variables routinely available before hospital discharge and which has been previously validated in more than 200,000 patients across 6 countries in its original version, and in nearly 120,000 patients in its simplified version. Patients will be randomly assigned to the intervention group or usual care group. The primary outcome will be the first 30-day unplanned readmission or all-cause mortality. The primary analysis will be a comparison between two groups according to the intention-to-treat principle. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT03496896
Study type Interventional
Source University Hospital Inselspital, Berne
Contact Jacques Donzé, MD, MSc
Phone 031/632.57.69
Status Recruiting
Phase N/A
Start date April 3, 2018
Completion date December 31, 2019

See also
  Status Clinical Trial Phase
Completed NCT03066492 - Evaluation of a Hospital Discharge Clinic to Improve Care Coordination and Reduce Rehospitalization in Low Income Adults N/A
Recruiting NCT03666793 - Comprehensive Management of Drug Prescriptions Throughout the Elderly Person's Hospital Care N/A
Active, not recruiting NCT03733665 - HES and NICOR Data Linkage for Cardiac Failure Population Analysis
Recruiting NCT02689076 - Regional Data Exchange to Improve Care for Veterans After Non-VA Hospitalization N/A
Recruiting NCT03528850 - Stony Brook Telehealth Study N/A
Recruiting NCT03256734 - Does a Complex Care Discharge Planning Initiative Reduce Unplanned Hospital Readmissions? (G78717-Readmits)
Completed NCT02752997 - Reducing 30-day Readmissions in Patients With Heart Failure Through Pharmacist Discharge Medication Services N/A
Not yet recruiting NCT02815462 - Impact of Implementing a Real Time Frequent Admitter Risk Score (FAM-FACE-SG) on Readmission Rates N/A
Completed NCT01893931 - Use of a Brief Phone Call After ED Discharge N/A
Completed NCT01292096 - Intervening With and Improving Care for Patients at Risk for Frequent Hospital Admissions Phase 1